Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Haemocell (UK) introduces autologous blood unit:

This article was originally published in Clinica

Executive Summary

Haemocell (UK) has introduced its System 350 low volume, autologous blood processing unit, which features a patented filtration system to wash and separate collected blood. The device is suitable for collecting blood lost during or after surgery. Processing is completed, with blood ready for reinfusion, within minutes, the company claims. Prepacked, disposable intra-operative collection, filter, and post-operative collection sets are available. The post-operative set converts from intra-operative to post-operative drainage for orthopaedic procedures. Haemocell estimates that over 3.25 million operations will be performed in the UK this year. While 2.4 million units of blood are collected in the UK every year, demand increases 4% annually.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts